Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BIOA
KROS
Add up to 3 more stocks
BIOA
BioAge Labs Inc.
-1.10%
$6.29-0.07Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$236.82M
52W Range
$5.04 - $25.96
KROS
Keros Therapeutics, Inc.
-4.43%
$11.01-0.51Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$218.30M
52W Range
$9.69 - $22.55
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.63 | 0.83 |
| P/S Ratio | 22.87 | 14.54 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 99.4% | 94.7% |
| Operating Margin | -1026.3% | 28.9% |
| Net Margin | -912.3% | -553.9% |
| ROE | -25.2% | -31.7% |
| ROA | -23.8% | -28.9% |
| ROIC | -28.1% | -36.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 17.19 | 21.96 |
| Quick Ratio | 17.19 | 21.96 |
| Debt/Equity | 0.01 | 0.06 |
| Interest Coverage | -133.11 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.